Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
HCC1395
TNBC
Basal B
Gefitinib
EGFR
ErbB
9258.024
uM
5.95730
7.40140
-0.9790 -0.9801 4.9999 0.2284
0.9586
0.5251
HCC1395
TNBC
Basal B
Gefitinib
EGFR
ErbB
7816.016
uM
12.91910
24.28270
-0.2709 -1.0000 1.7409 0.1554
0.9617
1.1183
HCC1395
TNBC
Basal B
Gefitinib
EGFR
ErbB
9254.049
uM
6.73770
7.3520
-0.2727 -0.2734 4.9990 0.1444
0.9644
0.8730
HCC1395
TNBC
Basal B
Gefitinib
EGFR
ErbB
7815.016
uM
27.86290
33.04340
0.1471 -0.6729 4.9999 0.0165
0.9782
0.4370
HCC1395
TNBC
Basal B
Gefitinib
EGFR
ErbB
7813.016
uM
6.6530
8.02730
-0.7767 -0.7782 4.9983 0.1663
0.9794
0.8531
HCC1395
TNBC
Basal B
Gefitinib
EGFR
ErbB
7814.016
uM
8.07790
51.84210
0.1222 -1.0000 0.5910 0.1669
0.9925
0.8623
HCC1395
TNBC
Basal B
Geldanamycin
HSP90
HSP90
9254.049
uM
0.74413
2.46190
-0.0421 -0.2443 0.3325 0.4007
0.8238
0.8730
HCC1395
TNBC
Basal B
Geldanamycin
HSP90
HSP90
7813.012
uM
0.01813
0.02165
-0.0705 -0.0323 0.3528 0.6395
0.8356
1.0493
HCC1395
TNBC
Basal B
Geldanamycin
HSP90
HSP90
9258.024
uM
0.02376
0.02636
-0.5399 -0.3387 4.9898 0.8590
0.9527
0.5251
HCC1395
TNBC
Basal B
Geldanamycin
HSP90
HSP90
7814.04
uM
0.05508
0.06471
-0.1717 -0.1078 1.2119 0.6135
0.9892
0.8711
HCC1395
TNBC
Basal B
Gemcitabine
DNA replication
DNA replication
7813.011
uM
inf
2.35980
0.6153 0.5805 4.9965 0.1441
0.7307
0.8718
HCC1395
TNBC
Basal B
Gemcitabine
DNA replication
DNA replication
9254.12
uM
7.13690
0.45857
0.3715 0.4768 1.1190 0.2056
0.8450
1.1139
HCC1395
TNBC
Basal B
Gemcitabine
DNA replication
DNA replication
9258.03
uM
0.05903
0.23991
-0.6420 -0.5382 0.5211 0.7273
0.9026
0.4015
HCC1395
TNBC
Basal B
Gemcitabine
DNA replication
DNA replication
9258.011
uM
0.61775
0.55858
-0.0576 0.0419 0.8693 0.4128
0.9716
0.6984
HCC1395
TNBC
Basal B
Gemcitabine
DNA replication
DNA replication
7814.011
uM
0.12816
0.10485
0.0751 0.0440 0.4591 0.5277
0.9834
0.9472
HCC1395
TNBC
Basal B
Glycyl-H-1152
ROCK2
12084.16
uM
12.49510
36.59980
-0.0127 -0.6415 0.7681 0.1579
0.9673
1.1178
HCC1395
TNBC
Basal B
Glycyl-H-1152
ROCK2
12000.169
uM
5.15510
75.12560
-0.0066 -1.0000 0.4101 0.2688
0.9786
0.8565
HCC1395
TNBC
Basal B
GM6001
MMP
MMP
7436.096
uM
inf
inf
0.8287 0.8287 0.0000 0.0732
-0.0129
1.3979
HCC1395
TNBC
Basal B
GSK1070916
AURK
AURK
9258.001
uM
0.09421
1.1910
-0.9841 -1.0000 0.4330 0.6113
0.8765
0.7137
HCC1395
TNBC
Basal B
GSK1070916
AURK
AURK
9254.001
uM
5.38610
6.70950
-1.0000 -0.9998 5.0000 0.3079
0.9082
0.3986
HCC1395
TNBC
Basal B
GSK1070916
AURK
AURK
7816.001
uM
0.59860
2.77790
-0.9806 -1.0000 0.7158 0.4383
0.9545
1.0243
HCC1395
TNBC
Basal B
GSK1070916
AURK
AURK
7813.001
uM
5.56960
8.06020
-0.9735 -1.0000 2.9723 0.1992
0.9944
0.7338
HCC1395
TNBC
Basal B
GSK1838705A
IGF1R
RTK
7436.091
uM
inf
inf
-0.9110 -0.9110 0.0000 0.2752
0.5479
1.2489
HCC1395
TNBC
Basal B
GSK1838705A
IGF1R
RTK
7435.098
uM
3.30950
3.29770
-0.4957 0.0088 5.0000 0.3285
0.6442
0.7702
HCC1395
TNBC
Basal B
GSK1838705A
IGF1R
RTK
7435.091
uM
3.60990
6.22790
-1.0000 -1.0000 2.0145 0.5103
0.9880
0.5716